Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

BLUE JET HEALTHCARE 2023-24 Annual Report Analysis
Wed, 18 Sep

BLUE JET HEALTHCARE has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

BLUE JET HEALTHCARE Income Statement Analysis

  • Operating income during the year fell 1.3% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 0.2% YoY during the fiscal. Operating profit margins witnessed a fall and down at 30.8% in FY24 as against 30.4% in FY23.
  • Depreciation charges increased by 12.0% and finance costs decreased by 88.2% YoY, respectively.
  • Other income grew by 20.5% YoY.
  • Net profit for the year grew by 2.3% YoY.
  • Net profit margins during the year grew from 22.2% in FY23 to 23.0% in FY24.

BLUE JET HEALTHCARE Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 7,210 7,116 -1.3%
Other income Rs m 240 289 20.5%
Total Revenues Rs m 7,449 7,405 -0.6%
Gross profit Rs m 2,191 2,195 0.2%
Depreciation Rs m 251 281 12.0%
Interest Rs m 14 2 -88.2%
Profit before tax Rs m 2,166 2,201 1.6%
Tax Rs m 566 563 -0.4%
Profit after tax Rs m 1,600 1,638 2.3%
Gross profit margin % 30.4 30.8
Effective tax rate % 26.1 25.6
Net profit margin % 22.2 23.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Must See: These Segments are Witnessing Incredible Growth with Modi's Push

BLUE JET HEALTHCARE Balance Sheet Analysis

  • The company's current liabilities during FY24 stood at Rs 4 billion as compared to Rs 3 billion in FY23, thereby witnessing an increase of 13.6%.
  • Current assets rose 6% and stood at Rs 9 billion, while fixed assets rose 79% and stood at Rs 4 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 12 billion as against Rs 10 billion during FY23, thereby witnessing a growth of 21%.

BLUE JET HEALTHCARE Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 6,815 8,452 24.0
 
Current Liabilities Rs m 3,184 3,616 13.6
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 10,066 12,145 20.7
 
Current assets Rs m 8,096 8,613 6.4
Fixed Assets Rs m 1,970 3,532 79.3
Total Assets Rs m 10,066 12,145 20.7
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



BLUE JET HEALTHCARE Cash Flow Statement Analysis

  • BLUE JET HEALTHCARE's cash flow from operating activities (CFO) during FY24 stood at Rs 2 billion, an improvement of 70.4% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -3 billion, an improvement of 79.1% on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs -20 million, an improvement of 53% on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs -245 million from the Rs -99 million net cash flows seen during FY23.

BLUE JET HEALTHCARE Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 1,416 2,413 70.4%
Cash Flow from Investing Activities Rs m -1,473 -2,638 -
Cash Flow from Financing Activities Rs m -42 -20 -
Net Cash Flow Rs m -99 -245 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for BLUE JET HEALTHCARE

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 9.4, an improvement from the EPS of Rs 9.2 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 530.0, stands at 58.4 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 10.9 times, while the price to sales ratio stands at 12.9 times.
  • The company's price to cash flow (P/CF) ratio stood at 34.0 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 41.6 41.0
TTM Earnings per share Rs 9.2 9.4
Diluted earnings per share Rs 9.2 9.4
Price to Cash Flow x 0.0 34.0
TTM P/E ratio x 0.0 58.4
Price / Book Value ratio x 0.0 7.7
Market Cap Rs m 0 65,279
Dividends per share (Unadj.) Rs 0.0 1.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for BLUE JET HEALTHCARE

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 2.4x during FY24, from 2.5x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio improved and stood at 1,368.0x during FY24, from 160.4x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company declined and down at 19.4% during FY24, from 23.5% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company declined and down at 26.1% during FY24, from 32.0% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company declined and down at 13.5% during FY24, from 16.0% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 2.5 2.4
Debtors’ Days Days 121 91
Interest coverage x 160.4 1,368.0
Debt to equity ratio x 0.0 0.0
Return on assets % 16.0 13.5
Return on equity % 23.5 19.4
Return on capital employed % 32.0 26.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how BLUE JET HEALTHCARE has performed over the last 5 years, please visit here.

BLUE JET HEALTHCARE Share Price Performance

Over the last one year, BLUE JET HEALTHCARE share price has moved up from Rs 0.0 to Rs 530.0, registering a gain of Rs 530.0 or around 0.0%.

Overall, the S&P BSE SENSEX is up 23.2% over the year.

(To know more, check out historical annual results for BLUE JET HEALTHCARE and quarterly results for BLUE JET HEALTHCARE)

Annual Report FAQs

What is the current share price of BLUE JET HEALTHCARE?

BLUE JET HEALTHCARE currently trades at Rs 533.7 per share. You can check out the latest share price performance of BLUE JET HEALTHCARE here...

What was the revenue of BLUE JET HEALTHCARE in FY24? How does it compare to earlier years?

The revenues of BLUE JET HEALTHCARE stood at Rs 7,405 m in FY24, which was down -0.6% compared to Rs 7,449 m reported in FY23.

BLUE JET HEALTHCARE's revenue has grown from Rs 5,440 m in FY20 to Rs 7,405 m in FY24.

Over the past 5 years, the revenue of BLUE JET HEALTHCARE has grown at a CAGR of 8.0%.

What was the net profit of BLUE JET HEALTHCARE in FY24? How does it compare to earlier years?

The net profit of BLUE JET HEALTHCARE stood at Rs 1,638 m in FY24, which was up 2.3% compared to Rs 1,600 m reported in FY23.

This compares to a net profit of Rs 1,816 m in FY22 and a net profit of Rs 1,358 m in FY21.

Over the past 5 years, BLUE JET HEALTHCARE net profit has grown at a CAGR of 3.1%.

What does the cash flow statement of BLUE JET HEALTHCARE reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of BLUE JET HEALTHCARE reveals:

  • Cash flow from operations increased in FY24 and stood at Rs 2,413 m as compared to Rs 1,416 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs -2,638 m as compared to Rs -1,473 m in FY23.
  • Cash flow from financial activity increased in FY24 and stood at Rs -20 m as compared to Rs -42 m in FY23.

Here's the cash flow statement of BLUE JET HEALTHCARE for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations1,2271,2931,4641,4162,413
From Investments-452-507-760-1,473-2,638
From Financial Activity-725-275-561-42-20
Net Cashflow50511142-99-245

What does the Key Ratio analysis of BLUE JET HEALTHCARE reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of BLUE JET HEALTHCARE reveals:

  • Operating profit margins witnessed a fall and down at 30.8% in FY24 as against 30.4% in FY23.
  • Net profit margins grew from 22.2% in FY23 to 23.0% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.0 as compared to 0.0 in FY23.

Here's the ratio/financial analysis of BLUE JET HEALTHCARE for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)39.740.236.530.430.8
Net Profit Margin (%)26.927.226.622.223.0
Debt to Equity Ratio (x)0.20.10.00.00.0

 

Equitymaster requests your view! Post a comment on "BLUE JET HEALTHCARE 2023-24 Annual Report Analysis". Click here!